首页> 美国卫生研究院文献>Drug Design Development and Therapy >Potential Use of Microbial Surfactant in Microemulsion Drug Delivery System: A Systematic Review
【2h】

Potential Use of Microbial Surfactant in Microemulsion Drug Delivery System: A Systematic Review

机译:微生物表面活性剂在微乳剂给药系统中的潜在应用:系统综述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Microemulsions drug delivery systems (MDDS) have been known to increase the bioavailability of hydrophobic drugs. The main challenge of the MDDS is the development of an effective and safe system for drug carriage and delivery. Biosurfactants are preferred surface-active molecules because of their lower toxicity and safe characteristics when compared to synthetic surfactants. Glycolipid and lipopeptide are the most common biosurfactants that were tested for MDDS. The main goal of the present systematic review was to estimate the available evidence on the role of biosurfactant in the development of MDDS.
机译:已知微乳液药物递送系统(MDDS)可增加疏水性药物的生物利用度。 MDDS的主要挑战是开发有效且安全的药物运输和运送系统。生物表面活性剂是优选的表面活性分子,因为与合成表面活性剂相比,它们具有较低的毒性和安全特性。糖脂和脂肽是经测试的MDDS最常见的生物表面活性剂。本系统综述的主要目标是估计有关生物表面活性剂在MDDS发育中的作用的可用证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号